Neuroendocrine
DiscoveriesAnti-cancer drug shows incredible promise in phase 1 human clinical trials
A clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with cancers.
Joseph Shavit![](https://www.thebrighterside.news/uploads/2024/04/95ac29_948a6641a9184d37b34662e08e4a9469mv2.png?auto=webp&auto=webp&optimize=high&quality=70&width=1440)